Clinical Trials Browser

Phase 2 × Leukemia, Plasma Cell × liposomal doxorubicin × Clear all

NCT01328236 2011-09-22

Bortezomib

Phase 2 Unknown

Other hematologic neoplasmPlasma cell

Leukemia, Plasma Cell, Multiple Myeloma